Both in Pharmaceuticals
Allarity Therapeutics vs Neuphoria Therapeutics
Over the past year ALLR returned −18.1% and NEUP returned −31.7%; their daily moves had a correlation of 0.18.
ALLR −18.1% NEUP −31.7%Growth of $1, one year, split-adjusted
| Metric | ALLR | NEUP |
|---|---|---|
| Price | $1.13 | $2.99 |
| Market cap | $18.0M | $16.2M |
| Today | +15.58% | −1.64% |
| 1 month | +13.0% | −13.3% |
| 6 months | −19.3% | −44.6% |
| Year to date | +4.6% | −22.9% |
| 1 year | −22.1% | −34.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 52.1× | — |
| Net cash | -$5.3M | — |
| Dividend yield | — | — |
| Volatility (60d) | 74.9% | 27.7% |
| Short % of float | 1.1% | 0.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).